Literature DB >> 1827827

IgM anti-Fc gamma R autoantibodies trigger neutrophil degranulation.

P Boros1, J A Odin, T Muryoi, S K Masur, C Bona, J C Unkeless.   

Abstract

Anti-Fc gamma R IgM monoclonal antibodies (mAbs) isolated from lipopolysaccharide-stimulated spleen cells from tightskin (TSK) mice were found to be polyspecific, reacting with a wide variety of molecules, including double-stranded DNA, topoisomerase, RNA polymerase, and different collagen types. Approximately 60% of the polyspecific IgM mAbs have anti-Fc gamma R specificity. These anti-Fc gamma R mAbs induce the release of hydrolases from both azurophil and specific granules of human neutrophils. 25-45% of the total cellular content (determined in Nonidet P-40 lysates) of neutrophil elastase, 10-25% of beta-glucuronidase, and 30-50% of alkaline phosphatase was released after incubation with the mAbs. The degranulation process was accompanied by dramatic morphological changes shown by scanning and transmission electron microscopy. The release of hydrolytic enzymes stimulated by the IgM anti-Fc gamma R mAbs was inhibited by preincubation of neutrophils with Fab fragments of either anti-human Fc gamma RII (IV.3) or anti-human Fc gamma RIII (3G8) mAbs. The binding of the anti-Fc gamma R TSK mAbs to human neutrophils was inhibited by Fab fragments of mAb 3G8. However, we found that the TSK anti-Fc gamma R mAbs do not bind to human Fc gamma RII expressed in either CHO cells or the P388D1 mouse macrophage cell line. Since the enzyme release could be inhibited by Fab fragments of mAb IV.3, we suggest that the signal transduction may require Fc gamma RII activation subsequent to crosslinking of the glycan phosphatidyl inositol-anchored Fc gamma RIII-1. These data demonstrate for the first time that polyspecific autoantibodies with Fc gamma R specificity can trigger neutrophil enzyme release via human Fc gamma RIII-1 in vitro and indicate a possible role for such autoantibodies in autoimmune inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827827      PMCID: PMC2190825          DOI: 10.1084/jem.173.6.1473

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies.

Authors:  Y Hirata; T Taga; M Hibi; N Nakano; T Hirano; T Kishimoto
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

2.  Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies.

Authors:  M F Tosi; M Berger
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

3.  T cell receptor/CD3 negative variants are unresponsive to stimulation through the Ly-6 encoded molecule, TAP.

Authors:  A Bamezai; H Reiser; K L Rock
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

4.  Molecular cloning of a human immunoglobulin G Fc receptor.

Authors:  M L Hibbs; L Bonadonna; B M Scott; I F McKenzie; P M Hogarth
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids.

Authors:  K C Petroni; L Shen; P M Guyre
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

6.  Multiple transcription start sites, DNase I-hypersensitive sites, and an opposite-strand exon in the 5' region of the CHO dhfr gene.

Authors:  P J Mitchell; A M Carothers; J H Han; J D Harding; E Kas; L Venolia; L A Chasin
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

7.  Lipid analysis of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase. Palmitoylation of inositol results in resistance to phosphatidylinositol-specific phospholipase C.

Authors:  W L Roberts; J J Myher; A Kuksis; M G Low; T L Rosenberry
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

8.  Pleiotropic loss of activation pathways in a T-cell receptor alpha-chain deletion variant of a cytolytic T-cell clone.

Authors:  A M Schmitt-Verhulst; A Guimezanes; C Boyer; M Poenie; R Tsien; M Buferne; C Hua; L Leserman
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

9.  T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.

Authors:  J L Ceuppens; F J Bloemmen; J P Van Wauwe
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.

Authors:  I Anegón; M C Cuturi; G Trinchieri; B Perussia
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  13 in total

1.  CD16b associates with high-density, detergent-resistant membranes in human neutrophils.

Authors:  Maria J G Fernandes; Emmanuelle Rollet-Labelle; Guillaume Paré; Sébastien Marois; Marie-Lisane Tremblay; Jean-Luc Teillaud; Paul H Naccache
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

2.  Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner.

Authors:  J E Salmon; S S Millard; N L Brogle; R P Kimberly
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 3.  The biology and pathology of Fc receptors.

Authors:  M Sandor; R G Lynch
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

Review 4.  Fc receptor-mediated signal transduction.

Authors:  C T Lin; Z Shen; P Boros; J C Unkeless
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

5.  Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye.

Authors:  Ulrich Schraermeyer; Sylvie Julien
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-22       Impact factor: 3.117

6.  No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis.

Authors:  W Y Tse; S Abadeh; A McTiernan; R Jefferis; C O Savage; D Adu
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

7.  Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA.

Authors:  R C van Schie; M E Wilson
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

8.  Isotype-specific cross-linking of select human Fc gamma R isoforms triggers release of IL-6.

Authors:  A J Duits; L A Aarden; L K Ernst; P J Capel; J G van de Winkel
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

9.  On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

Authors:  P W Parren; P A Warmerdam; L C Boeije; J Arts; N A Westerdaal; A Vlug; P J Capel; L A Aarden; J G van de Winkel
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Recombinant soluble Fc gamma RII inhibits immune complex precipitation.

Authors:  A L Gavin; B D Wines; M S Powell; P M Hogarth
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.